Related Experiment Video
Updated: Dec 30, 2025

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
829
Sugar-free Workplace: A Step for Fighting Obesity
Jaafar Sahned1, Dereen Mohammed Saeed2, Subhasis Misra1
1Surgery, Brandon Regional Hospital, Brandon, USA.
Cureus
|January 16, 2020
Summary
The global obesity pandemic is worsening due to factors like poor diet and inactivity. A sugar-free workplace policy is a promising strategy to combat rising obesity rates and improve public health.
Area of Science:
- Public Health
- Nutrition Science
- Epidemiology
Background:
- The global obesity pandemic has escalated over recent decades, posing significant public health and economic challenges.
- Obesity is a major risk factor for severe health conditions, including cardiovascular disease, hypertension, stroke, diabetes mellitus, and cancer.
- Associated social and psychological issues like anxiety and depression further compound the impact of obesity.
Purpose of the Study:
- To highlight the critical role of sugar consumption in the global obesity pandemic.
- To propose a sugar-free workplace policy as a viable strategy to mitigate obesity.
- To underscore the public health implications of dietary habits and sedentary lifestyles.
Main Methods:
- Review of current epidemiological data on obesity incidence and trends.
- Analysis of dietary factors contributing to obesity, with a focus on sugar intake.
- Evaluation of potential public health interventions, specifically workplace policies.
Main Results:
- Sugar is identified as a primary driver of the escalating obesity pandemic.
- Decreased physical activity and unhealthy dietary patterns are key contributing factors.
- Workplace policies aimed at reducing sugar consumption show promise in obesity prevention.
Conclusions:
- Addressing sugar intake is crucial for combating the global obesity crisis.
- Implementing workplace policies that eliminate sugar can be an effective public health intervention.
- A multi-faceted approach, including dietary changes and increased physical activity, is necessary to reverse obesity trends.
More Related Videos
Related Concept Videos
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients
168
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
168
Sugars as Energy Storage Molecules
9.7K
Sugar (a simple carbohydrate) metabolism (chemical reactions) is a classic example of the many cellular processes that use and produce energy. Living things consume sugar as a major energy source because sugar molecules have considerable energy stored within their bonds. Consumed carbohydrates have their origins in photosynthesizing organisms like plants. During photosynthesis, plants use the energy of sunlight to convert carbon dioxide gas into sugar molecules, like glucose. Because this...
9.7K
Oral Hypoglycemic Agents: Sulfonylureas
678
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
678
Oral Hypoglycemic Agents: Biguanides and Glitazones
538
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
538
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
477
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
477

